Le Lézard
Classified in: Science and technology
Subjects: Product/Service, Personnel, Award

SAIC CEO Nazzic Keene Receives March of Dimes Corporate Heroine Award


Nazzic Keene, CEO of Science Applications International Corp. (NYSE: SAIC), was honored by the March of Dimes, the nation's leader in the fight for the health of all moms and babies, with the Corporate Heroine Award. Keene was honored for her commitment to helping those in need and for leveraging her platform as CEO of a $6.5 billion company to be a role model and instill a spirit of giving back.

The March of Dimes Heroines of Washington Awards Gala is one of Washington's most esteemed events, recognizing and honoring women in the Washington, D.C. metro area for their dedication to community service. The awards honor women in categories including healthcare, real estate, professional services, technology, public sector, rising heroine, and lifetime achievement.

Keene was chosen for giving back to her community through feats of volunteerism that go above and beyond expectations. Keene's dedication to causes ? including volunteering her own time and resources to organizations whose missions resonate with her, and inspiring a spirit of giving through SAIC and the organizations she leads ? have solidified her placement as a finalist.

"Nazzic has instilled a culture at SAIC that never hesitates to give back," said SAIC Board Chair Donna Morea. "Her personal efforts and inspiring leadership make a positive difference within SAIC, with thousands of people in the Washington area, and beyond. To those she's supported and served, ?heroine' is an overdue title."

Since 2001, the March of Dimes has honored 118 "heroines" and raised more than $3.1 million to support the organization's efforts to fight premature birth and birth defects. Heroines of Washington Awards Gala guests include directors, CEOs, and other high-level individuals from local corporations and government agencies.

About SAIC

SAIC® is a premier technology integrator solving our nation's most complex modernization and readiness challenges. Our robust portfolio of offerings across the defense, space, civilian, and intelligence markets includes high-end solutions in engineering, IT, and mission solutions. Using our expertise and understanding of existing and emerging technologies, we integrate the best components from our own portfolio and our partner ecosystem to deliver innovative, effective, and efficient solutions.

We are 23,000 strong; driven by mission, united by purpose, and inspired by opportunities. Headquartered in Reston, Virginia, SAIC has pro forma annual revenues of approximately $6.5 billion. For more information, visit saic.com. For ongoing news, please visit our newsroom.

About March of Dimes

The March of Dimes is the leading nonprofit organization for pregnancy and baby health. For nearly 80 years, moms and babies have benefited from March of Dimes research, education, vaccines, and breakthroughs. To learn more about our solutions or donate to the March of Dimes, visit marchofdimes.org and nacersano.org. For detailed national, state and local perinatal statistics, visit peristats.org. You can also find us on Facebook or follow us on Instagram and Twitter.

Forward-Looking Statements

Certain statements in this release contain or are based on "forward-looking" information within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by words such as "expects," "intends," "plans," "anticipates," "believes," "estimates," "guidance," and similar words or phrases. Forward-looking statements in this release may include, among others, estimates of future revenues, operating income, earnings, earnings per share, charges, total contract value, backlog, outstanding shares and cash flows, as well as statements about future dividends, share repurchases and other capital deployment plans. Such statements are not guarantees of future performance and involve risk, uncertainties and assumptions, and actual results may differ materially from the guidance and other forward-looking statements made in this release as a result of various factors. Risks, uncertainties and assumptions that could cause or contribute to these material differences include those discussed in the "Risk Factors," "Management's Discussion and Analysis of Financial Condition and Results of Operations" and "Legal Proceedings" sections of our Annual Report on Form 10-K, as updated in any subsequent Quarterly Reports on Form 10-Q and other filings with the SEC, which may be viewed or obtained through the Investor Relations section of our website at saic.com or on the SEC's website at sec.gov. Due to such risks, uncertainties and assumptions you are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date hereof. SAIC expressly disclaims any duty to update any forward-looking statement provided in this release to reflect subsequent events, actual results or changes in SAIC's expectations. SAIC also disclaims any duty to comment upon or correct information that may be contained in reports published by investment analysts or others.


These press releases may also interest you

26 avr 2024
OKX, a leading Web3 technology company, today announced the integration of Side Protocol with the OKX Wallet. Side Protocol is a cross-chain middleware protocol designed to enable seamless communication and asset transfer between heterogeneous...

26 avr 2024
OKX, a leading Web3 technology company, today announced the integration of Biturbo with the OKX Wallet. Bitrubo is an innovative layer 2 solution that brings the power of Ethereum's smart contracts to the Bitcoin network. Biturbo is designed as an...

26 avr 2024
The report titled "Cognitive Security Market by Component (Services, Solutions), Security Type (Application, Cloud, Cybersecurity), Application, Deployment Mode, Enterprise Type, Vertical - Global Forecast 2024-2030" is now available on...

26 avr 2024
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

26 avr 2024
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

26 avr 2024
The partnership was unveiled internally at the Franchisor's annual convention in Las Vegas, NV in December 2023, eliciting...



News published on and distributed by: